GRP
NRXP icon

Global Retirement Partners’s NRX Pharmaceuticals NRXP Stock Holding History

Global Retirement Partners’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
+33,300
New +$110K ﹤0.01% 1846
2025
Q4 		$107K Buy
+39,300
New +$105K ﹤0.01% 1872

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Global Retirement Partners's NRXP Position: Q2 2026 in Review

Global Retirement Partners opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 33,300 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #1846 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in NRXP as recently as Q4 2025.

Global Retirement Partners first reported a position in NRXP in Q4 2025 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Global Retirement Partners held 33,300 shares of NRX Pharmaceuticals worth $136K as of Q2 2026.
  • NRX Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1846 holding.
  • Global Retirement Partners first reported a position in NRX Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.